

          -  Hypersensitivity to chloroquine or hydroxychloroquine;

          -  Women during pregnancy;

          -  Severe heart, lung, kidney, brain, blood diseases or other important systemic
             diseases;

          -  Participants with retinal disease, hearing loss;

          -  Participants with severe neurological and mental illness;

          -  Subjects were considered to be unable to complete the study, or not suitable for the
             study by researchers.

        Exit criteria:

          -  Subjects asked to withdraw the study

          -  Subject will benefit if withdraw according to researchers' suggestions
      